Definitive Healthcare Corp expected to post earnings of 9 cents a share - Earnings Preview

Definitive Healthcare

03/08/2024 03:56

* Definitive Healthcare Corp  DH.OQ   DH.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 5
for the period ending March 31 2024
    * The Framingham Massachusetts-based  company is expected to
report a 3.6% increase in revenue to $63.165 million from $60.96
million a year ago, according to the mean estimate from 12
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Definitive Healthcare
Corp is
for earnings of 8 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 8
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Definitive
Healthcare Corp is $8.00​, above​ its last closing price
of $3.70. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   0.08        0.08       0.08      Met     -1.9
 Dec. 31 0001  0.08        0.08       0.07      Missed  -8.4
 Jan. 1 0001   0.07        0.06       0.09      Beat    44.6​
 Jan. 1 0001   0.06        0.06       0.08      Beat    44.6
 ​​Jan.        0.05        0.04       0.06      Beat    35
 1 0001                                                 
 Dec. 31 2022  0.04        0.04       0.07      Beat    67.7​
 Sep. 30 2022  0.05        0.05       0.06      Beat    27.7
 Jan. 1 0001   0.05        0.05       0.06      Beat    18.3
 This summary was machine generated August 3 at 02:56 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)